Jana Sawynok

Affiliations: 
Dalhousie University, Halifax, Nova Scotia, Canada 
Area:
pain, opioids
Google:
"Jana Sawynok"
Mean distance: 17.13 (cluster 37)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sawynok J, Zinger C. (2016) Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain. Expert Opinion On Pharmacotherapy
Sawynok J. (2015) Adenosine receptor targets for pain. Neuroscience
Nascimento FP, Macedo-Júnior SJ, Pamplona FA, et al. (2015) Adenosine A1 receptor-dependent antinociception induced by inosine in mice: pharmacological, genetic and biochemical aspects. Molecular Neurobiology. 51: 1368-78
Sawynok J. (2014) Topical and peripheral ketamine as an analgesic. Anesthesia and Analgesia. 119: 170-8
Sawynok J, Liu J. (2014) Contributions of peripheral, spinal, and supraspinal actions to analgesia. European Journal of Pharmacology. 734: 114-21
Sawynok J. (2014) Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development. European Journal of Pain (London, England). 18: 465-81
Sawynok J, Reid AR, Liu J. (2013) Spinal and peripheral adenosine A₁ receptors contribute to antinociception by tramadol in the formalin test in mice. European Journal of Pharmacology. 714: 373-8
Liu J, Reid AR, Sawynok J. (2013) Antinociception by systemically-administered acetaminophen (paracetamol) involves spinal serotonin 5-HT7 and adenosine A1 receptors, as well as peripheral adenosine A1 receptors. Neuroscience Letters. 536: 64-8
Liu J, Reid AR, Sawynok J. (2013) Spinal serotonin 5-HT7 and adenosine A1 receptors, as well as peripheral adenosine A1 receptors, are involved in antinociception by systemically administered amitriptyline. European Journal of Pharmacology. 698: 213-9
Sawynok J, Reid AR. (2012) Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A₁ receptors. European Journal of Pharmacology. 674: 248-54
See more...